US Capital Partners was engaged by Provia Laboratories as its strategic advisor for a $2 million convertible debt financing.
Provia will use the new financing to expand sales and marketing activities, retire existing debt and provide general working capital as the business continues to grow.
“We are extremely pleased to be assisting Provia with its business financing needs in a strategic investment banking role, as the company moves into the next phase of its business expansion,” said Jeffrey Sweeney, chairman and CEO at US Capital Partners.
“At the core of Provia’s vision, we believe in helping individuals benefit from their own cells,” said Howard Greenman, CEO at Provia. “Store-A-Tooth offers one of the few opportunities we have as parents to collect and preserve our children’s stem cells when our children are young, and their cells are healthy. We have prepared our business to scale, and plan to work nationally with dental and oral surgery offices, expand our direct-to-consumer activities, and bring our technology to additional markets through strategic partnerships.”
Provia is a revenue-generating stem cell processing, manufacturing and bio-storage company
Since 1998, San Francisco-based US Capital Partners has been providing well-structured, custom finance solutions to private and public companies in the U.S. and abroad.